Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2651-2655, December 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhoads, A. R.
Right arrow Articles by West, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhoads, A. R.
Right arrow Articles by West, W. L.

Cyclic 3',5'-Nucleotide Monophosphate Phosphodiesterase Activity in Hepatomas of Different Growth Rates1

Allen R. Rhoads, Harold P. Morris and William L. West

Departments of Biochemistry [A. R. R., H. P. M.] and Pharmacology [W. L. W.], Howard University College of Medicine, Washington, D. C. 20001

Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity was determined for seven hepatomas of different growth rates and host livers. Activity was measured in the soluble fraction of the cell (78,000 x g) in the presence and absence of 40 mM imidazole.

Phosphodiesterase activity in all hepatomas studied was decreased to levels of 60% or less of control livers of non-tumor-bearing rats. Corresponding decreases in the imidazole-stimulated phosphodiesterase activity were observed for hepatomas. Conversely, phosphodiesterase activity of 24-hr regenerating liver was elevated slightly above those for sham-operated controls. Reduced phosphodiesterase activity was observed only in host livers of animals bearing hepatomas 7800 and 7777.

In the presence of imidazole, phosphodiesterase activity in all tissues was stimulated 110 to 135% of basal levels. Differences in the pH-activity profiles were observed between phosphodiesterase from normal and neoplastic liver. Phosphodiesterase of normal liver had a well-defined pH optimum at 7.4, whereas the activity from hepatoma had a broader optimum ranging from 6.2 to 7.4.

Kinetic plots of the hydrolysis of cyclic adenosine 3',5'-monophosphate exhibited anomolous behavior suggesting that both normal and neoplastic tissue contain at least two different phosphodiesterase activities. Apparent Michaelis constants for the high- and low-affinity enzymes ranged from 2.5 to 7.6 µM and from 39 to 54 µM, respectively.

1 This work was supported in part by USPHS Grants CA-11491-03 and CA-10729.

Received 6/13/72. Accepted 8/25/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.